Effect of luteal phase elevation in core temperature on forearm blood flow during exercise

1997 ◽  
Vol 82 (4) ◽  
pp. 1079-1083 ◽  
Author(s):  
Margaret A. Kolka ◽  
Lou A. Stephenson

Kolka, Margaret A., and Lou A. Stephenson. Effect of luteal phase elevation in core temperature on forearm blood flow during exercise. J. Appl. Physiol. 82(4): 1079–1083, 1997.—Forearm blood flow (FBF) as an index of skin blood flow in the forearm was measured in five healthy women by venous occlusion plethysmography during leg exercise at 80% peak aerobic power and ambient temperature of 35°C (relative humidity 22%; dew-point temperature 10°C). Resting esophageal temperature (Tes) was 0.3 ± 0.1°C higher in the midluteal than in the early follicular phase of the menstrual cycle ( P < 0.05). Resting FBF was not different between menstrual cycle phases. The Tes threshold for onset of skin vasodilation was higher (37.4 ± 0.2°C) in midluteal than in early follicular phase (37.0 ± 0.1°C; P < 0.05). The slope of the FBF to Tes relationship was not different between menstrual cycle phases (14.0 ± 4.2 ml ⋅ 100 ml−1 ⋅ min−1 ⋅ °C−1for early follicular and 16.3 ± 3.2 ml ⋅ 100 ml−1 ⋅ min−1 ⋅ °C−1for midluteal phase). Plateau FBF was higher during exercise in midluteal (14.6 ± 2.2 ml ⋅ 100 ml−1 ⋅ min−1 ⋅ °C−1) compared with early follicular phase (10.9 ± 2.4 ml ⋅ 100 ml−1 ⋅ min−1 ⋅ °C−1; P < 0.05). The attenuation of the increase in FBF to Tes occurred when Tes was 0.6°C higher and at higher FBF in midluteal than in early follicular experiments ( P < 0.05). In summary, the FBF response is different during exercise in the two menstrual cycle phases studied. After the attenuation of the increase in FBF and while Tes was still increasing, the greater FBF in the midluteal phase may have been due to the effects of increased endogenous reproductive endocrines on the cutaneous vasculature.

1975 ◽  
Vol 79 (4) ◽  
pp. 625-634 ◽  
Author(s):  
Elwyn M. Grimes ◽  
Irwin E. Thompson ◽  
Melvin L. Taymor

ABSTRACT Thirty-one ovulatory women between 20 and 33 years of age were given 150 μg of synthetic LH-RH during different phases of the menstrual cycle. Five patients were studied during the early follicular phase (days 4–7); 10 patients during the late follicular phase (days 9–12); 6 patients during the "LH Surge"; 5 patients during the early luteal phase (days 14–16); 3 patients during mid-luteal phase (days 17–21); and 2 patients during late luteal phase (days 22–27). Oestrogen, progesterone, FSH and LH levels were determined from 30 min prior to LH-RH administration to 90 min thereafter in all cases. LH response to LH-RH increased progressively during the follicular phase. Enhanced pituitary responsiveness to LH-RH occurred at mid-cycle for both LH and FSH and maximum LH responses occurred during the "LH Surge" and early luteal phase. LH responses during the mid and late luteal phases were similar to late follicular phase responses. There were no significant differences between FSH responses during the early follicular, late follicular, mid-luteal and late luteal phases. Maximum pituitary responsiveness appears to occur in a gonadal steroid milieu of high oestrogen levels in association with rising but low progesterone levels. Progesterone or a crucial oestrogen: progesterone ratio may in fact potentiate pituitary release of LH during the early stages of corpus luteum formation. Pituitary responsiveness to LH-RH correlates positively with basal LH and oestrogen levels during the menstrual cycle and with the oestrogen:progesterone ratio during the luteal phase.


1982 ◽  
Vol 100 (3) ◽  
pp. 427-433 ◽  
Author(s):  
N. Kruyt ◽  
R. Rolland

Abstract. The release of cortisol, 17α-OH-progesterone, androstenedione and testosterone during a standardized ACTH-stimulation test was investigated in three different stages of the normal menstrual cycle, to conclude if there is any stage dependency on the release of these hormones. No statistically significant differences were observed between the three stages concerning cortisol and testosterone increase. The increase of androstenedione in the pre-ovulatory stage was significantly higher than that seen during the early follicular phase of the cycle. The increase of 17α-OH-progesterone in the luteal phase was significantly less than that of both the early and late follicular stages of the cycle. Progesterone levels showed a small, but significant increase after ACTH-stimulation, in both the early and late stage of the follicular phase. However, the levels remained within the normal range of the follicular phase. In the luteal phase no increase was seen after ACTH-stimulation. Oestradtiol-17β levels did not change at all after ACTH-stimulation. The stage dependency of androstenedione and 17α-OH-progesterone is discussed. The described stage-dependency different increase of 17α-OH-progesterone release can be of importance when the results of ACTH-tests are evaluated to detect carriers of congenital adrenal hyperplasia.


1978 ◽  
Vol 89 (1) ◽  
pp. 48-59 ◽  
Author(s):  
M. Ferin ◽  
J. Bogumil ◽  
J. Drewes ◽  
I. Dyrenfurth ◽  
R. Jewelewicz ◽  
...  

ABSTRACT The effects of prolonged gonadotrophin-releasing hormone (GnRH) infusions on LH, FSH, oestrogens and progesterone secretion were studied in female rhesus monkeys at various times of the menstrual cycle and after castration. GnRH was infused at the rate of 15 μg/h for 48 h. This resulted in mean peripheral GnRH levels of 398 ± 31.5 pg/ml (± se) as measured by radioimmunoassay. As expected the pattern of gonadotrophin responses to GnRH varied considerably with the phase of the menstrual cycle. The largest LH increase was seen during the late follicular phase (6-fold over baseline), with a 3-fold increase during the luteal phase and a 2-fold one during the early follicular phase and in the period following the LH surge. Significant FSH increases (4-fold) were seen only during the follicular phase. Oestrogens increased about 2-fold within 4 h of the start of the infusion during the early follicular phase. In the late follicular phase and during the LH surge, they declined within 24 and 1 h, respectively. Large progesterone increases were seen only during the luteal phase. Of special interest is the fact that the increase in gonadotrophin secretion could not be maintained for the entire duration of the experiment even though GnRH continued to be infused at rates sufficient to elicit initial increases of several fold over baseline. Gonadotrophin release declined 4–28 h after the initial stimulation. A further decrease below pre-infusion control levels was particularly evident during the midcycle surge and, for FSH, after ovariectomy. These results indicate that a continuous mode of administration may rapidly induce a desensitization phenomenon at the level of the gonadotroph.


1999 ◽  
Vol 84 (1) ◽  
pp. 192-197 ◽  
Author(s):  
Alison M. Duncan ◽  
Barbara E. Merz ◽  
Xia Xu ◽  
Theodore C. Nagel ◽  
William R. Phipps ◽  
...  

Soy isoflavones are hypothesized to be responsible for changes in hormone action associated with reduced breast cancer risk. To test this hypothesis, we studied the effects of isoflavone consumption in 14 premenopausal women. Isoflavones were consumed in soy protein powders and provided relative to body weight (control diet, 10 ± 1.1; low isoflavone diet, 64 ± 9.2; high isoflavone diet, 128 ± 16 mg/day) for three menstrual cycles plus 9 days in a randomized cross-over design. During the last 6 weeks of each diet period, plasma was collected every other day for analysis of estrogens, progesterone, LH, and FSH. Diet effects were assessed during each of four distinctly defined menstrual cycle phases. Plasma from the early follicular phase was analyzed for androgens, cortisol, thyroid hormones, insulin, PRL, and sex hormone-binding globulin. The low isoflavone diet decreased LH (P = 0.009) and FSH (P = 0.04) levels during the periovulatory phase. The high isoflavone diet decreased free T3 (P = 0.02) and dehydroepiandrosterone sulfate (P = 0.02) levels during the early follicular phase and estrone levels during the midfollicular phase (P = 0.02). No other significant changes were observed in hormone concentrations or in the length of the menstrual cycle, follicular phase, or luteal phase. Endometrial biopsies performed in the luteal phase of cycle 3 of each diet period revealed no effect of isoflavone consumption on histological dating. These data suggest that effects on plasma hormones and the menstrual cycle are not likely to be the primary mechanisms by which isoflavones may prevent cancer in premenopausal women.


2008 ◽  
Vol 105 (4) ◽  
pp. 1156-1165 ◽  
Author(s):  
Glen P. Kenny ◽  
Emily Leclair ◽  
Ronald J. Sigal ◽  
W. Shane Journeay ◽  
Donald Kilby ◽  
...  

It is unknown whether menstrual cycle or oral contraceptive (OC) use influences nonthermal control of postexercise heat loss responses. We evaluated the effect of menstrual cycle and OC use on the activation of heat loss responses during a passive heating protocol performed pre- and postexercise. Women without OC ( n = 8) underwent pre- and postexercise passive heating during the early follicular phase (FP) and midluteal phase (LP). Women with OC ( n = 8) underwent testing during the active pill consumption (high exogenous hormone phase, HH) and placebo (low exogenous hormone phase, LH) weeks. After a 60-min habituation at 26°C, subjects donned a liquid conditioned suit. Mean skin temperature was clamped at ∼32.5°C for ∼15 min and then gradually increased, and the absolute esophageal temperature at which the onset of forearm vasodilation (Thvd) and upper back sweating (Thsw) were noted. Subjects then cycled for 30 min at 75% V̇o2 peak followed by a 15-min seated recovery. A second passive heating was then performed to establish postexercise values for Thvd and Thsw. Between 2 and 15 min postexercise, mean arterial pressure (MAP) remained significantly below baseline ( P < 0.05) by 10 ± 1 and 11 ± 1 mmHg for the FP/LH and LP/HH, respectively. MAP was not different between cycle phases. During LP/HH, Thvd was 0.16 ± 0.24°C greater than FP/LH preexercise ( P = 0.020) and 0.15 ± 0.23°C greater than FP/LH postexercise ( P = 0.017). During LP/HH, Thsw was 0.17 ± 0.23°C greater than FP/LH preexercise ( P = 0.016) and 0.18 ± 0.16°C greater than FP/LH postexercise ( P = 0.001). Postexercise thresholds were significantly greater ( P ≤ 0.001) than preexercise during both FP/LH (Thvd, 0.22 ± 0.03°C; Thsw, 0.13 ± 0.03°C) and LP/HH (Thvd, 0.21 ± 0.03°C; Thsw, 0.14 ± 0.03°C); however, the effect of exercise was similar between LP/HH and FP/LH. No effect of OC use was observed. We conclude that neither menstrual cycle nor OC use modifies the magnitude of the postexercise elevation in Thvd and Thsw.


1982 ◽  
Vol 99 (4) ◽  
pp. 481-486 ◽  
Author(s):  
S. Baumgarten ◽  
A. Römmler ◽  
K.G. Post ◽  
J. Hammerstein

Abstract. The objective of this study was to re-investigate the capacity of pituitary prolactin (Prl) and thyrotrophin (TSH) secretion throughout the normal menstrual cycle to respond to repeated thyrotrophin releasing hormone (TRH) stimulation analogous to the double luteinizing hormone-releasing hormone (LRH) stimulation test. This test has been shown to be a sensitive parameter for oestrogenic effects on the gonadotrophs. In addition, the volunteers were selected carefully on the basis of ovulatory cycles and otherwise normal endocrine function. In 9 women a combined LRH/TRH double stimulation test was performed during the early follicular, periovulatory and mid-luteal phases. TRH (200 μg) and LRH (25 μg) each were given iv twice, 2 h apart. Basal and LRH stimulated luteinizing hormone (LH) and follicle stimulating hormone (FSH) were found to follow characteristic cyclic response patterns. The LH responses after both LRH stimulations were greatest in the periovulatory phase; Δ1 and Δ2 were higher in the mid-luteal phase than in the follicular phase. Maximum FSH response to LRH was found during the periovulatory phase, but the FSH response in the early follicular phase was greater than that found in the mid-luteal phase. In contrast, basal and TRH stimulated serum concentrations of TSH and Prl remained constant throughout the cycle. The gonadotrophin ratios Δ2:Δ1 were generally greater than 1. They increased from 1.4 in the early follicular phase to 3.0 in the late follicular phase, concomitant with the rise in oestrogens. The Δ2: Δ1 ratios for TSH and Prl were less than 1, ranging from 0.66 to 0.98 for TSH and from 0.26 to 0.99 for Prl. They did not show any cyclic changes. Thus, this study shows that after LRH/TRH double stimulation, the gonadotrophin but not the Prl and TSH responses vary with the physiological changes in oestrogens during the menstrual cycle. The supposed mechanism of oestrogen effects on pituitary hormone secretion and their possible clinical significance are discussed.


Motricidade ◽  
2017 ◽  
Vol 13 (3) ◽  
pp. 31 ◽  
Author(s):  
Gabriel Rodrigues Neto ◽  
Jefferson Silva Novaes ◽  
Adenilson Targino de Araújo Júnior ◽  
Júlio César Gomes Silva ◽  
Rodrigo Poderoso Souza ◽  
...  

The present study aimed to determine the influence of low-load (LL) resistance exercise (RE) with blood flow restriction (BFR) on systolic blood pressure (SBP), diastolic blood pressure (DBP), mean blood pressure (MBP), heart rate (HR), double product (DP) and oxygen saturation (SpO2) during the phases of the menstrual cycle (MC). Thirty untrained women were randomly and proportionally divided into three groups: HI = high-intensity exercises (80% of one-repetition maximum (1RM)); LL = low-load exercises (20% of 1RM); and LL+BFR = LL exercises combined with BFR. The exercise sessions were performed during the 3rd-4th days (follicular phase), 16th day (ovulatory phase) and the 24th-26th days (luteal phase) of the MC. Before and immediately after the exercises, SBP, DBP, HR and SpO2 were evaluated. We observed an increase in SBP, HR and DP in the three phases of the MC for all groups (p < 0.05). Groups LL and/or LL+BFR exhibited a greater increase in SBP, DBP, MBP, HR and DP when compared with the HI group (p < 0.05), and in the three groups, SpO2 was not reduced (p > 0.05). There was a significant effect of the MC phases on HR and DP (p < 0.05). We conclude that the three groups exhibited increased SBP, HR and DP; however, SpO2 was not different. Furthermore, groups LL and LL+BFR exhibited greater increases in hemodynamics, and the MC phases seem to influence only HR and DP.


2019 ◽  
Author(s):  
Zahira Z. Cohen ◽  
Neta Gotlieb ◽  
Offer Erez ◽  
Arnon Wiznitzer ◽  
Oded Arbel ◽  
...  

AbstractThe menstrual cycle is characterized partially by fluctuations of the ovarian hormones estradiol (E2) and progesterone (P4), which are implicated in the regulation of cognition. Research on attention in the different stages of the menstrual cycle is sparse, and the three attentional networks (alerting, orienting and executive) and their interaction were not explored during the menstrual cycle. In the current study, we used the ANT-I (attentional network test – interactions) to examine two groups of women: naturally cycling (NC) – those with a regular menstrual cycle, and oral contraceptives (OC) – those using OC and characterized with low and steady ovarian hormone levels. We tested their performance at two time points that fit, in natural cycles, the early follicular phase and the early luteal phase. We found no differences in performance between NC and OC in low ovarian hormone states (Both phases for the OC group and early follicular phase for the NC group). However, the NC group in the early luteal phase exhibited the same pattern of responses for alerting and no-alerting conditions, resulting in a better conflict resolution (executive) when attention is oriented to the target. Results-driven exploratory regression analysis of E2 and P4 suggested that change in P4 from early follicular to early luteal phases was a mediator for the alerting effect found. In conclusion, the alerting state found with or without alertness manipulation suggests that there is a progesterone mediated activation of the alerting system during the mid-luteal phase.


2000 ◽  
Vol 98 (2) ◽  
pp. 201-207 ◽  
Author(s):  
A. V. EMMANUEL ◽  
M. A. KAMM ◽  
R. W. BEARD

Pelvic venous congestion is a common cause of chronic pelvic pain in women of reproductive age. Although this condition represents a functional disturbance of the pelvic circulation which is related to the menstrual cycle, its aetiology remains unknown. Indirect techniques demonstrate that the vasoconstrictive reflex response of the microcirculation of the foot to a rise in venous pressure is attenuated throughout the menstrual cycle. We wished to develop a simple and non-invasive direct measure of pelvic blood flow to aid diagnosis of this condition. Laser doppler blood flux measurements of the skin of the big toe and of the vaginal and rectal mucosa in the follicular and luteal phases of the menstrual cycle in 12 healthy asymptomatic premenopausal women (mean age 30 years) with regular cycles and in four healthy asymptomatic postmenopausal women (mean age 59 years) were carried out both in the supine position and in response to 40° head-up tilt. The coefficient of variation of resting vaginal flux was lower for measurements in postmenopausal women (0.04) and in premenopausal women in the follicular phase (0.07) compared with those in the luteal phase (0.16). At rest, vaginal blood flow was higher than rectal and skin flux in both premenopausal and postmenopausal women. In the follicular phase a decrease in flow was observed in response to head-up tilt in the skin (-32.0%), vagina (-34.3%) and rectum (-9.4%). In the luteal phase this reflex was attenuated at these three sites (-8.6%, +6.7% and +7.4% respectively). There were no significant reflex changes in postmenopausal women. Thus laser doppler fluximetry is a reproducible method for comparing the flux of blood in the microcirculation of the skin and of the vaginal and rectal mucosa. The skin is the least sensitive site for testing vascular reactivity in response to cyclical changes. The vaginal and rectal microcirculations are the most sensitive sites for testing visceral cyclical reactivity, and have the advantage of direct anatomical relevance. The follicular phase of the menstrual cycle is associated with greatest vascular reactivity and is the most appropriate phase during which to test for abnormal vascular responses.


Sign in / Sign up

Export Citation Format

Share Document